Market Performance & Trends - S&P futures and NASDAQ are slightly up, with NASDAQ up by approximately six points [1] - The Dow Jones Industrial Average has reached new record highs, closing above 48,000 [1] - NASDAQ is just over 2% away from its all-time high [2] - The market exhibits a tendency to trend upwards, with new highs often leading to further highs [3] Earnings & Profitability - With 90% of results in, companies have demonstrated an average topline growth of 8% and bottom line growth of 12%, indicating increased profitability [6] - Earnings growth was widespread across 10 of 11 sectors [6] Hyperscaler Leverage & Debt - Hyperscalers are generally underlevered and have the flexibility to increase debt on their balance sheets [7][8] - Some hyperscalers are borrowing at rates close to the US government rate, indicating market support for their debt [9] Risks & Vulnerabilities - The interconnectedness of deals and the syndication of debt among a focused number of companies pose a potential vulnerability for the markets [11] - It is difficult to discern who will bear the risk if deals do not perform as expected, requiring close monitoring of escape clauses in private contracts [11][12][13]

Core Insights - Earnings season presents opportunities for lesser-known companies to gain attention, with three stocks highlighted for potential comebacks if their earnings reports are favorable [2] Company Overview - Scholar Rock Holding Corp. (NASDAQ: SRRK) is a biotech firm focused on developing protein therapeutics for neuromuscular diseases [3] - The lead asset, apitegromab, targets Type 2 and Type 3 Spinal Muscular Atrophy (SMA) and has shown promising Phase 3 data, indicating strong potential for regulatory approval in 2026 [4] Financial Performance - Scholar Rock's shares have declined approximately 33% year-to-date due to manufacturing site issues, raising short-term concerns [4] - The company is projected to report a loss per share of 76 cents for the third quarter, with no revenue expected yet [6] Clinical Development - A Phase 2 study of apitegromab demonstrated over 54% lean mass preservation compared to control when combined with GLP-1 agonist tirzepatide, indicating the drug's therapeutic promise [5] - Investors should look for updates on apitegromab and other drugs in the pipeline during the upcoming earnings report [6] Market Sentiment - Quarterly earnings reports can significantly impact share prices, with Scholar Rock, along with Globant and NiCE, being identified as companies that may see a rebound if they deliver strong earnings [7]

Core Insights - The 2025 Q3 earnings season has shown positive results, with American Express (AXP) and Palantir (PLTR) achieving record-breaking performances due to strong business momentum [1][9] American Express (AXP) - AXP reported adjusted EPS growth of 19% and a 10% increase in sales, leading to a positive post-earnings reaction and an upgrade in sales and EPS outlook for the current year [2][3] - Quarterly sales reached $18.4 billion, a record for AXP, driven by successful launches of updated Platinum Cards and increased Card Member spending, indicating a healthy consumer environment [3] Palantir (PLTR) - PLTR achieved quarterly sales of $1.2 billion, marking a 63% year-over-year increase, with US commercial revenue surging 121% and US government revenue rising 52% [4] - The company secured over 50 deals worth at least $10 million, resulting in a Total Contract Value (TCV) of $2.8 billion, which is a 340% increase year-over-year [4][5] - Similar to AXP, PLTR raised its current-year sales, adjusted operating income, and adjusted free cash flow guidance, prompting analysts to increase their EPS expectations [5]

Core Insights - The article discusses updates on companies during earnings season, highlighting specific performance metrics and strategic developments in the business development company (BDC) sector and consumer staples industry. Group 1: Business Development Companies (BDCs) - Hercules Capital (HTGC) reported a strong third-quarter performance with total investment income of $138.1 million, bringing the year-to-date figure to a record $395.1 million, up 6.4% from the same period in 2024 [6] - Third-quarter net investment income reached $88.6 million, contributing to a year-to-date total of $254.7 million, which is up 4.1% compared to the previous year [6] - HTGC's third-quarter originations hit $846 million, totaling $2.87 billion for the first three quarters, positioning the company to exceed the 2024 record of $3.12 billion [7] - The net asset value (NAV) of HTGC is currently $12.05, reflecting a 1.8% increase from the previous quarter, despite challenges in the BDC sector [10] - HTGC achieved 122% coverage of its $0.40 quarterly base distribution, indicating strong financial health and the potential for supplemental payments [11] Group 2: Consumer Staples - Kimberly-Clark (KMB) announced an unexpected acquisition of Kenvue (KVUE), aiming to create a global health and wellness leader, which led to a 12.5% drop in KMB's shares while KVUE's shares rose by 17% [13] - The acquisition is seen as a strategic move to enhance market penetration similar to Proctor & Gamble, with both companies highlighting expected synergies [14] - The volatility in KMB's shares is anticipated to continue until the deal closes in the second half of 2026, but the recommendation is to hold KMB shares despite the recent drop [15]

Core Insights - The earnings season for mega-cap tech stocks has been notably positive, characterized by earnings beats, raised guidance, and optimistic expectations for future revenue and profit growth [1] Group 1 - Many closely-watched tech giants experienced significant price appreciation following the release of their earnings results [1]

Skip to Main Content Skip to Search This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. By Jack Hough Nov 07, 2025, 3:22 pm EST Share Resize Reprints MSFT AMZN GOOGL Winnebago Industries bounced 29% afte ...

The Needham, Mass.-based company earned an adjusted $1.50 a share on net sales of $1.63 billion in the September quarter. Analysts polled by FactSet had expected earnings of $1.32 a share on sales of $1.6 billion. On a year-over-year basis, SharkNinja earnings rose 24% while net sales increased 14%. For the full year, SharkNinja now expects sales to increase 15% to 15.5%, above its prior guidance of 13% to 15% growth. It also raised its target for adjusted earnings for the year to $5.05 to $5.15, reflecting ...

Core Insights - Investors have reacted negatively to disappointing earnings reports from companies like Netflix and Chipotle, leading to significant declines in their stock prices [1][2] - The overall performance of S&P 500 companies has been positive, but the rewards for beating earnings expectations have been minimal, while penalties for missing expectations have been severe [2][4] Earnings Performance - Companies that missed earnings expectations experienced an average stock decline of nearly 5% around their earnings release, which is worse than the five-year average decline of -2.6% [3][8] - Conversely, companies that beat earnings expectations saw an average stock increase of only 0.1%, below the five-year average increase of 0.9% [3][5] Market Sentiment - The current earnings season has shown a trend where traders are more pessimistic, despite a record number of positive earnings surprises among S&P 500 companies [4][5] - Over 64% of S&P 500 companies that reported earnings exceeded consensus EPS estimates by at least one standard deviation, compared to a historical average of 49% over the past 25 years [5][8] Macro Environment - The earnings season is taking place against a backdrop of macroeconomic volatility, including renewed trade policy uncertainty and concerns regarding bank lending [9]

Market Overview - Pre-market indexes are showing positive movement after a period of volatility, particularly since the government shutdown began in early October [1] - Among major indexes, only the small-cap Russell 2000 has been positive over the past five trading days, but it remains negative for the past month [2] Labor Market Indicators - Challenger Job Cuts for October reached 153,704, marking a +183% increase month over month and +175% year over year, indicating the worst October for job layoffs since 2009 [3] - The Chicago Fed Labor Market Indicator shows an unchanged unemployment estimate at +4.36%, with a +40% probability that this figure may be higher [4] Q3 Earnings Results - ConocoPhillips (COP) reported a +15% earnings beat with $1.61 per share, but shares are down -10% year to date [5] - AstraZeneca (AZN) had a modest earnings beat of 5 cents, with shares up +3.5% in early trading, having gained nearly +24% year to date [5] - Ralph Lauren (RL) outperformed expectations with earnings of $3.79 per share, boosting shares by +1.9% and up +37% year to date [6] - Planet Fitness (PLNT) reported earnings of 80 cents per share, exceeding expectations, and is now positive year to date with a +15.3% gain [6] - TripAdvisor (TRIP) saw a +7.9% gain after an +11% earnings beat, indicating strong consumer demand for vacations [7] - Tapestry (TPR) posted earnings of $1.38 per share, exceeding estimates, but shares are down -9% due to projected revenue slowdowns [7] - Moderna (MRNA) outperformed expectations by +76.3% with a loss of -$0.51 per share, but shares are still down more than -30% year to date [8]

Core Insights - Antero Resources Corporation (AR) experienced a 3.8% increase in stock price despite reporting lower-than-expected earnings, indicating strong natural gas demand driven by data centers and LNG exports [1][9] Financial Performance - Adjusted earnings for Q3 2025 were 15 cents per share, missing the Zacks Consensus Estimate of 22 cents, but improved from a loss of 12 cents in the same quarter last year [1] - Total quarterly revenues reached $1,213.99 million, surpassing the Zacks Consensus Estimate of $1,183.64 million and increasing from $1,055.9 million year-over-year [2] Production Metrics - Total production for Q3 was 315 billion cubic feet equivalent (Bcfe), slightly up from 313 Bcfe a year ago and exceeding the estimate of 314 Bcfe [4] - Natural gas production accounted for 64% of total production, totaling 202 Bcf, a 1% increase from 200 Bcf year-over-year [4] - Oil production decreased by 28% to 619 thousand barrels (MBbls) from 856 MBbls in the previous year [5] Price Realization - Weighted natural-gas-equivalent price realization was $3.59 per thousand cubic feet equivalent (Mcfe), up from $3.14 a year ago [6] - Realized prices for natural gas increased by 46% to $3.12 per Mcf from $2.13 year-over-year [6] - Oil price realization was $50.65 per barrel (Bbl), down from $61.59 a year ago [6] Operating Expenses - Total operating expenses rose to $1,095.9 million from $1,080.9 million in the previous year [8] - Average lease operating costs increased by 11% to 10 cents per Mcfe [10] Capital Expenditures and Financials - Antero Resources spent $172 million on drilling and completion operations in Q3 [11] - The company reported a long-term debt of $1.3 billion as of June 30, 2025 [11] Future Outlook - Production guidance for 2025 is projected between 3.4-3.45 Bcfe/d [12] - The full-year drilling and completion capital budget is estimated at $650 million to $675 million [12]